- Summary on the U.S. Supreme Court’s Opinion on Rutledge v. PCMA Dec 10, 2020 WASHINGTON, DC (December 10, 2020) – Today, the United States Supreme Court issued its opinion in... read more
- Pharmacy Groups Say New Rebate Rule Does Not Do Enough to Support Patients Nov 24, 2020 WASHINGTON, DC (November 24, 2020) – Today the country’s leading pharmacy groups issued this statement on... read more
- ACHC and NASP Partner to Elevate Specialty Pharmacy Practice Nov 03, 2020 CARY, NC – November 3, 2020 – Accreditation Commission for Health Care (ACHC) announces its partnership... read more
- Guiding Principles for Safe and Efficacious COVID-19 Vaccine Development, Distribution, Allocation, and Mass Immunization Oct 22, 2020 NASP along with the Pharmaceutical Supply and Payment Chain Coalition offers the following guiding principles for... read more
- National Association of Specialty Pharmacy (NASP) Inducted New Chairman of the Board and Announced Scholarship, NASP Challenge and Abstract Award Recipients During the 2020 Annual Meeting & Expo Virtual Experience Sep 18, 2020 WASHINGTON, DC – September 18, 2020– National Association of Specialty Pharmacy (NASP) shined the spotlight on... read more
- National Association of Specialty Pharmacy (NASP) Announces Awards and Welcomes New Board Members at the 2020 Annual Meeting & Expo Virtual Experience Sep 15, 2020 WASHINGTON, DC – September 15, 2020 – National Association of Specialty Pharmacy (NASP) was pleased to... read more
- NASP Supports the SAFE TO WORK ACT Jul 30, 2020 WASHINGTON DC, (July 30, 2020) – As we continue to navigate this unprecedented time of uncertainty,... read more
- Pharmacy Groups tell HHS that Any Action on Rebate Rule Must Involve Fixing Pharmacy DIR Fees Jul 29, 2020 WASHINGTON, DC (July 29, 2020) – As we continue to navigate this unprecedented time of uncertainty,... read more
- NASP Submits Comments to CMS Jul 23, 2020 WASHINGTON, DC (July 23, 2020) – The National Association of Specialty Pharmacy (NASP) recently submitted comments... read more
- NASP Member EVERSANA’s Data & Analytics platform to be used by ICER to conduct indirect treatment comparisons to support value assessments Jul 23, 2020 EVERSANA, the leading provider of global commercial services to the life sciences industry, today announced a partnership with ICER to advance standards for the usage of transparent, replicable and robust indirect treatment comparisons in health technology assessments. read more